Abstract B26: Phase 1b trial of investigational NEDD8-activating enzyme (NAE) inhibitor pevonedistat (TAK-924/MLN4924) in combination with docetaxel, paclitaxel/carboplatin, or gemcitabine in patients (pts) with solid tumors

A. Craig Lockhart; Todd M Bauer; R. Donald Harvey; Carrie B Lee; Charu Aggarwal; Roger B Cohen; Farhad Sedarati; Ling Wang; Hélène M Faessel; Bruce J Dezube; Sergio Santillana; Afshin Dowlati

doi:10.1158/1535-7163.TARG-15-B26

Back

Abstract B26: Phase 1b trial of investigational NEDD8-activating enzyme (NAE) inhibitor pevonedistat (TAK-924/MLN4924) in combination with docetaxel, paclitaxel/carboplatin, or gemcitabine in patients (pts) with solid tumors

Journal article

Peer reviewed

Abstract B26: Phase 1b trial of investigational NEDD8-activating enzyme (NAE) inhibitor pevonedistat (TAK-924/MLN4924) in combination with docetaxel, paclitaxel/carboplatin, or gemcitabine in patients (pts) with solid tumors

A. Craig Lockhart, Todd M Bauer, R. Donald Harvey, Carrie B Lee, Charu Aggarwal, Roger B Cohen, Farhad Sedarati, Ling Wang, Hélène M Faessel, Bruce J Dezube, …

Molecular cancer therapeutics, Vol.14(12 Supplement 2), pp.B26-B26

2015-12

DOI: https://doi.org/10.1158/1535-7163.TARG-15-B26

Metrics

6 Record Views

Details

Title: Abstract B26: Phase 1b trial of investigational NEDD8-activating enzyme (NAE) inhibitor pevonedistat (TAK-924/MLN4924) in combination with docetaxel, paclitaxel/carboplatin, or gemcitabine in patients (pts) with solid tumors
Creators: A. Craig Lockhart
Todd M Bauer
R. Donald Harvey
Carrie B Lee
Charu Aggarwal
Roger B Cohen
Farhad Sedarati
Ling Wang
Hélène M Faessel
Bruce J Dezube
Sergio Santillana
Afshin Dowlati
Publication Details: Molecular cancer therapeutics, Vol.14(12 Supplement 2), pp.B26-B26
Academic Unit: Miller School of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031598517802976